• Citer

An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer.

par Bonnefoi, H;Biganzoli, Laura ;Cufer, T;Mauriac, L;Hamilton, Andrew;Schaefer, P;Piccart-Gebhart, Martine
Référence Breast cancer research and treatment, 70, 1, page (55-63)
Publication Publié, 2001-11

Article révisé par les pairs

• Détails
• Contenu

Titre:	An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer.
Auteur:	Bonnefoi, H; Biganzoli, Laura; Cufer, T; Mauriac, L; Hamilton, Andrew; Schaefer, P; Piccart-Gebhart, Martine
Informations sur la publication:	Breast cancer research and treatment, 70, 1, page (55-63)
Statut de publication:	Publié, 2001-11
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adult
	Antibiotics, Antineoplastic -- administration & dosage
	Antimetabolites, Antineoplastic -- administration & dosage
	Antineoplastic Agents, Alkylating -- administration & dosage
	Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
	Antineoplastic Combined Chemotherapy Protocols -- adverse effects
	Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
	Breast Neoplasms -- drug therapy
	Breast Neoplasms -- pathology
	Breast Neoplasms -- surgery
	Cyclophosphamide -- administration & dosage
	Drug Administration Schedule
	Epirubicin -- administration & dosage
	Female
	Fluorouracil -- administration & dosage
	Humans
	Injections, Intravenous
	Middle Aged
	Severity of Illness Index
	Treatment Outcome
Note générale:	Clinical Trial
	Clinical Trial, Phase I
	Journal Article
Langue:	Anglais
Identificateurs:	urn:issn:0167-6806
	info:pmid/11768362